$~0
0[0.00%]
Last update: 11:13AM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
| Open- | Close- |
| Vol / Avg.0 / - | Mkt Cap3.000 |
| Day Range- - - | 52 Wk Range0.000 - 0.000 |
Vasamed Stock (OTC:VSMD), Key Statistics
Vasamed Stock (OTC: VSMD) analysis, key statistics.
Valuation Measures
Enterprise Value
2.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.5M
Total Assets
3.1M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
30.36%
Net Margin
-334.49%
EBIT Margin
-240.7%
EBITDA Margin
-154.96%
Operating Margin
-240.7%
Vasamed Stock (OTC:VSMD), Key Statistics
Vasamed Stock (OTC: VSMD) analysis, key statistics.
Valuation Measures
Enterprise Value
2.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.5M
Total Assets
3.1M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
30.36%
Net Margin
-334.49%
EBIT Margin
-240.7%
EBITDA Margin
-154.96%
Operating Margin
-240.7%
Vasamed Stock (OTC:VSMD), Key Statistics
Vasamed Stock (OTC: VSMD) analysis, key statistics.
Valuation Measures
Enterprise Value
2.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.5M
Total Assets
3.1M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
30.36%
Net Margin
-334.49%
EBIT Margin
-240.7%
EBITDA Margin
-154.96%
Operating Margin
-240.7%
Vasamed Stock (OTC:VSMD), Key Statistics
Vasamed Stock (OTC: VSMD) analysis, key statistics.
Valuation Measures
Enterprise Value
2.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.5M
Total Assets
3.1M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
30.36%
Net Margin
-334.49%
EBIT Margin
-240.7%
EBITDA Margin
-154.96%
Operating Margin
-240.7%
Vasamed Stock (OTC:VSMD), Key Statistics
Vasamed Stock (OTC: VSMD) analysis, key statistics.
Valuation Measures
Enterprise Value
2.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.5M
Total Assets
3.1M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
30.36%
Net Margin
-334.49%
EBIT Margin
-240.7%
EBITDA Margin
-154.96%
Operating Margin
-240.7%
Vasamed Stock (OTC:VSMD), Key Statistics
Vasamed Stock (OTC: VSMD) analysis, key statistics.
Valuation Measures
Enterprise Value
2.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.5M
Total Assets
3.1M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
30.36%
Net Margin
-334.49%
EBIT Margin
-240.7%
EBITDA Margin
-154.96%
Operating Margin
-240.7%
Vasamed Stock (OTC:VSMD), Key Statistics
Vasamed Stock (OTC: VSMD) analysis, key statistics.
Valuation Measures
Enterprise Value
2.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.5M
Total Assets
3.1M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
30.36%
Net Margin
-334.49%
EBIT Margin
-240.7%
EBITDA Margin
-154.96%
Operating Margin
-240.7%
Vasamed Stock (OTC:VSMD), Key Statistics
Vasamed Stock (OTC: VSMD) analysis, key statistics.
Valuation Measures
Enterprise Value
2.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
4.5M
Total Assets
3.1M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
30.36%
Net Margin
-334.49%
EBIT Margin
-240.7%
EBITDA Margin
-154.96%
Operating Margin
-240.7%